Nelfinavir/ritonavir reduces acinar injury but not inflammation during mouse caerulein pancreatitis

There is no clinical treatment that reduces acinar injury during pancreatitis. Human immunodeficiency virus (HIV) protease inhibitors (PI), including nelfinavir (NFV) and ritonavir (RTV), may reduce the rate of pancreatitis in HIV-infected patients. Since permeability transition pore (PTPC)-mediated...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Singh, Vijay P., Bren, Gary D., Algeciras-Schimnich, Alicia, Schnepple, David, Navina, Sarah, Rizza, Stacey A., Dawra, Rajinder K., Saluja, Ashok K., Chari, Suresh T., Vege, Santhi S., Badley, Andrew D.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Physiological Society 2009
Aiheet:
Inflammation/Immunity/Mediators
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2696210/
https://ncbi.nlm.nih.gov/pubmed/19282375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpgi.90642.2008
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia